Influencing Public Policy on Research and Clinical Endocrinology

Society Letters

The Endocrine Society produces and signs onto a range of letters to elected officials, Federal agencies, and other legislative and deliberative bodies.

  • Endocrine Society Comments on Section 1557 Rule
    August 13, 2019 | The Endocrine Society submitted comments to the Department of Health and Human Services expressing concerns over the administration's proposed revisions to the non-discrimination provisions set forth in Section 1557 of the Affordable Care Act which protect transgender individuals from discrimination. 
  • Letter to European Commission President-Elect
    August 7, 2019 | The Endocrine Society congratulated Dr. Ursula von der Leyen on her election to the Presidency of the European Commission and highlighted our shared priorities in public health and environmental toxicology, including endocrine-disrupting chemicals.
  • Letter to National Institute on Aging
    August 7, 2019 | The Endocrine Society commented on the development of the new NIA Longitudinal Rat Resource to study neural and behavioral trajectories of cognitive aging.  Our comments identified considerations relevant to behavioral assessment, measurement parameters of interest to endocrine scientists, general data management recommendations, and overarching considerations for the resource. 
  • Thank You to Assistant Administrator Alex Dunn
    July 30, 2019 | We wrote a letter to Assistant Administrator Alex Dunn of the Office of Chemical Safety and Pollution Prevention at the EPA tanking them for their taking time to meet with us to discuss shared scientific and public health priorites.  
  • Letter to Congress to Improve Pediatric Reference Ranges 
    July 19, 2019 | We joined a group of organizations calling on Congress  to improve pediatric reference intervals and ensure quality of care for our country's children.  
  • EMPOWER for Health Act Letter of Support
    July 17, 2019 | We signed a letter in support of the EMPOWER for Health Act which would reauthorize the Pediatric Subspecialty Loan Repayment Program
  • Sign-On Letter Regarding FTR Policies
    July 11, 2019 | The Endocrine Society signed on to a letter expressing collective and strong opposition to new policies on research using human fetal tissue (FTR) announced by the Department of Health and Human Services (HHS) on June 5, 2019. These policies would impose substantial barriers to and limit the responsible and ethical use of fetal tissue in critical research projects. 
  • Sign-on Letter Supporting Microbiome Research
    July 10, 2019 | We request that the Senate Appropriations Committee match the $10 million provided for microbiome research initiatives in the fiscal year (FY) 2020 Energy and Water appropriations bill passed by the House as part of H.R. 2740. Specifically, to support the continued development and operation of the National Microbiome Data Collective (NMDC). 
  • Endocrine Society Letter on EDC Fitness Check Roadmap
    July 9, 2019 | In our comments, we urge the Joint Research Centre to include the latest science on EDCs in the Fitness Check data collection, clarify potential regulatory actions under consideration for EDCs, and identify detailed actions and concrete steps towards a coherent strategy for addressing EDCs in the EU.
  • Letter of Support for NIH MCRU
    June 26, 2019 | Having learned of preliminary discussions to close or alter the operations of the Metabolic Clinical Research Unit (MCRU) at the NIH Clinical Center, we wrote to the Directors of the NIH and NIDDK in support of the MCRU and asking NIH and Clinical Center leadership to continue to support the operations of the MCRU in its current state.  

See all...

Society Testimony

Representing the Endocrine Society, our members strive to influence public policy related to research and clinical endocrinology issues by testifying before the United States Congress, Federal agencies, and other legislative and deliberative bodies.

See all...